| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |